U.S. markets closed

HTG Molecular Diagnostics, Inc. (HTGM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.3211+0.0063 (+2.00%)
At close: 03:59PM EST
0.3200 -0.00 (-0.34%)
After hours: 05:05PM EST

HTG Molecular Diagnostics, Inc.

3430 East Global Loop
Tucson, AZ 85706
United States
877 289 2615

IndustryDiagnostics & Research
Full Time Employees87

Key Executives

NameTitlePayExercisedYear Born
Mr. John L. LubniewskiPres, CEO & Director736.74kN/A1964
Mr. Shaun D. McMeansSr. VP, CFO, Sec. & Treasurer510.6kN/A1962
Mr. Byron T. LawsonSr. VP & Chief Commercial Officer440.3kN/A1975
Ms. Laura Lee GodlewskiSr. VP of Fin. & Admin.N/AN/A1980
Dr. Debra A. GordonSr. VP & Chief Legal CounselN/AN/A1960
Dr. Patrick C. RocheSr. VP of R&DN/AN/A1953
Dr. Stephen A. Barat Ph.D.Sr. VP of TherapeuticsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

Corporate Governance

HTG Molecular Diagnostics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.